{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:50:30Z","timestamp":1772164230510,"version":"3.50.1"},"reference-count":33,"publisher":"American Association for Cancer Research (AACR)","issue":"17","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The development of risk-directed treatment protocols over the last 25 years has resulted in an increase in the survival rates of children treated for cancer. As a consequence, there is a growing population of pediatric cancer survivors in which the long-term genotoxic effects of chemotherapy is unknown. We previously reported that children treated for acute lymphocytic leukemia have significantly elevated somatic mutant frequencies at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene in their peripheral T cells. To understand the molecular etiology of the increase in mutant frequencies following chemotherapy, we investigated the HPRT mutation spectra and the extent of clonal proliferation in 562 HPRT T cell mutant isolates of 87 blood samples from 47 subjects at diagnosis, during chemotherapy, and postchemotherapy. We observed a significant increase in the proportion of CpG transitions following treatment (13.6-23.3%) compared with healthy controls (4.0%) and a significant decrease in V(D)J-mediated deletions following treatment (0-6.8%) compared with healthy controls (17.0%). There was also a significant change in the class type percentage of V(D)J-mediated HPRT deletions following treatment. In addition, there was a &amp;gt;5-fold increase in T cell receptor gene usage\u2013defined mean clonal proliferation from diagnosis compared with the completion of chemotherapeutic intervention. These data indicate that unique genetic alterations and extensive clonal proliferation are occurring in children following treatment for acute lymphocytic leukemia that may influence long-term risks for multifactorial diseases, including secondary cancers. (Cancer Res 2006; 66(17): 8455-61)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-4015","type":"journal-article","created":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T18:49:59Z","timestamp":1157136599000},"page":"8455-8461","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of Genetic Alterations and Clonal Proliferation in Children Treated for Acute Lymphocytic Leukemia"],"prefix":"10.1158","volume":"66","author":[{"given":"Heather E.","family":"Kendall","sequence":"first","affiliation":[{"name":"1Department of Pediatrics,"},{"name":"4Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela M.","family":"Vacek","sequence":"additional","affiliation":[{"name":"3Medical Biostatistics and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jami L.","family":"Rivers","sequence":"additional","affiliation":[{"name":"2Vermont Cancer Center; and Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sederick C.","family":"Rice","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri L.","family":"Messier","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics,"},{"name":"2Vermont Cancer Center; and Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry A.","family":"Finette","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics,"},{"name":"2Vermont Cancer Center; and Departments of"},{"name":"4Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"2022061622124430600_B1","unstructured":"Gloeckler Ries LA, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program, 1975\u20131995. Bethesda (MD): National Cancer Institute; 1999. Report No.: SEER Program. NIH Pub. No. 99-4649."},{"key":"2022061622124430600_B2","doi-asserted-by":"crossref","unstructured":"Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukaemia\u2014current status and future perspectives. Lancet Oncol\u20082001; 2: 597\u2013607.","DOI":"10.1016\/S1470-2045(01)00516-2"},{"key":"2022061622124430600_B3","doi-asserted-by":"crossref","unstructured":"Stahnke K, Fulda S, Friesen C, Straub G, Debatin K-M. Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy. Blood\u20082001; 98: 3066\u201373.","DOI":"10.1182\/blood.V98.10.3066"},{"key":"2022061622124430600_B4","doi-asserted-by":"crossref","unstructured":"Friedman DL, Meadows AT. Late effects of childhood cancer therapy. Pediatr Clin North Am\u20082002; 49: 1083\u2013106, x.","DOI":"10.1016\/S0031-3955(02)00032-9"},{"key":"2022061622124430600_B5","doi-asserted-by":"crossref","unstructured":"Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst\u20082001; 93: 618\u201329.","DOI":"10.1093\/jnci\/93.8.618"},{"key":"2022061622124430600_B6","doi-asserted-by":"crossref","unstructured":"Finette BA, Homans AC, Albertini RJ. Emergence of genetic instability in children treated for leukemia. Science\u20082000; 288: 514\u20137.","DOI":"10.1126\/science.288.5465.514"},{"key":"2022061622124430600_B7","doi-asserted-by":"crossref","unstructured":"Rice SC, Vacek P, Homans AH, et al. Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia. Cancer Res\u20082004; 64: 4464\u201371.","DOI":"10.1158\/0008-5472.CAN-03-3940"},{"key":"2022061622124430600_B8","doi-asserted-by":"crossref","unstructured":"Finette BA, Sullivan LM, O'Neill JP, Nicklas JA, Vacek PM, Albertini RJ. Determination of HPRT mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutat Res\u20081994; 308: 223\u201331.","DOI":"10.1016\/0027-5107(94)90157-0"},{"key":"2022061622124430600_B9","doi-asserted-by":"crossref","unstructured":"Messier T, O'Neill JP, Hou S-M, Nicklas JA, Finette BA. In vivo transposition mediated by V(D)J recombinase in human T-lymphocytes. EMBO J\u20082003; 22: 1381\u20138.","DOI":"10.1093\/emboj\/cdg137"},{"key":"2022061622124430600_B10","doi-asserted-by":"crossref","unstructured":"Gibbs RA, Nguyen P-N, Edwards A, Civitello AB, Caskey CT. Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics\u20081990; 7: 235\u201344.","DOI":"10.1016\/0888-7543(90)90545-6"},{"key":"2022061622124430600_B11","unstructured":"Finette BA, Poseno T, Albertini RJ. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res\u20081996; 56: 1405\u201312."},{"key":"2022061622124430600_B12","unstructured":"Fuscoe JC, Zimmerman LJ, Lippert MJ, Nicklas JA, O'Neill JP, Albertini RJ. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes. Cancer Res\u20081991; 51: 6001\u20135."},{"key":"2022061622124430600_B13","doi-asserted-by":"crossref","unstructured":"Finette BA, Homans AC, Rivers J, Messier T, Albertini RJ. Accumulation of somatic mutations in proliferating T cell clones from children treated for leukemia. Leukemia\u20082001; 15: 1898\u2013905.","DOI":"10.1038\/sj.leu.2402306"},{"key":"2022061622124430600_B14","doi-asserted-by":"crossref","unstructured":"Nicklas JA, O'Neill JP, Albertini RJ. Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymphocytes. Mutat Res\u20081986; 173: 65\u201372.","DOI":"10.1016\/0165-7992(86)90013-8"},{"key":"2022061622124430600_B15","doi-asserted-by":"crossref","unstructured":"Abramson LS, Albertini RJ, Pachman LM, Finette BA. Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis. Clin Immunol\u20081999; 91: 61\u20137.","DOI":"10.1006\/clim.1998.4675"},{"key":"2022061622124430600_B16","doi-asserted-by":"crossref","unstructured":"Burkhart-Schultz KJ, Thompson CL, Jones IM. Spectrum of somatic mutation at the hypoxanthine phosphoribosyltransferase (hprt) gene of healthy people. Carcinogenesis\u20081996; 17: 1871\u201383.","DOI":"10.1093\/carcin\/17.9.1871"},{"key":"2022061622124430600_B17","doi-asserted-by":"crossref","unstructured":"Finette BA, Kendall H, Vacek PM. Mutational spectral analysis at the HPRT locus in healthy children. Mutat Res\u20082002; 505: 27\u201341.","DOI":"10.1016\/S0027-5107(02)00119-7"},{"key":"2022061622124430600_B18","doi-asserted-by":"crossref","unstructured":"Skandalis A, Ford BN, Glickman BW. Strand bias in mutation involving 5-methylcytosine deamination in the human hprt gene. Mutat Res\u20081994; 314: 21\u20136.","DOI":"10.1016\/0921-8777(94)90057-4"},{"key":"2022061622124430600_B19","doi-asserted-by":"crossref","unstructured":"Podlutsky A, Osterholm A-M, Hou S-M, Hofmaier A, Lambert B. Spectrum of point mutations in the coding region of the hypoxanthine-guanine phosporibosyltransferase (hprt) gene in human T-lymphocytes in vivo. Carcinogenesis\u20081998; 19: 557\u201366.","DOI":"10.1093\/carcin\/19.4.557"},{"key":"2022061622124430600_B20","doi-asserted-by":"crossref","unstructured":"Rideout WM III, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science\u20081990; 249: 1288\u201390.","DOI":"10.1126\/science.1697983"},{"key":"2022061622124430600_B21","doi-asserted-by":"crossref","unstructured":"Zingg J-M, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis\u20081997; 18: 869\u201382.","DOI":"10.1093\/carcin\/18.5.869"},{"key":"2022061622124430600_B22","doi-asserted-by":"crossref","unstructured":"Ek T, Mellander L, Andersson B, Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer\u20082005; 44: 461\u20138.","DOI":"10.1002\/pbc.20255"},{"key":"2022061622124430600_B23","doi-asserted-by":"crossref","unstructured":"O'Neill JP, Finette BA. Transition mutations at CpG dinucleotides are the most frequent in vivo spontaneous single base substitution mutation in the human HPRT gene. Environ Mol Mutagen\u20081998; 32: 188\u201391.","DOI":"10.1002\/(SICI)1098-2280(1998)32:2<188::AID-EM16>3.0.CO;2-Y"},{"key":"2022061622124430600_B24","doi-asserted-by":"crossref","unstructured":"Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet\u20081988; 78: 151\u20135.","DOI":"10.1007\/BF00278187"},{"key":"2022061622124430600_B25","doi-asserted-by":"crossref","unstructured":"Hsu GW, Ober M, Carell T, Beese LS. Error-prone replication of oxidatively damaged DNA by a high-fidelity DNA polymerase. Nature\u20082004; 431: 217\u201321.","DOI":"10.1038\/nature02908"},{"key":"2022061622124430600_B26","doi-asserted-by":"crossref","unstructured":"Groninger E, Meeuwsen-De Boer GJ, De Graaf SS, Kamps WA, De Bont ES. Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: a mitochondrial controlled pathway regulated by reactive oxygen species? Int J Oncol\u20082002; 21: 1339\u201345.","DOI":"10.3892\/ijo.21.6.1339"},{"key":"2022061622124430600_B27","doi-asserted-by":"crossref","unstructured":"Hirota H, Kubota M, Hashimoto H, et al. Analysis of hprt gene mutation following anti-cancer treatment in pediatric patients with acute leukemia. Mutat Res\u20081993; 319: 113\u201320.","DOI":"10.1016\/0165-1218(93)90069-P"},{"key":"2022061622124430600_B28","doi-asserted-by":"crossref","unstructured":"Tonegawa S. Somatic generation of antibody diversity. Nature\u20081983; 302: 575\u201381.","DOI":"10.1038\/302575a0"},{"key":"2022061622124430600_B29","unstructured":"Yoshioka M, O'Neill JP, Vacek PM, Finette BA. Gestational age and gender specific in utero V(D)J recombinase mediated deletions. Cancer Res\u20082001; 61: 3432\u20138."},{"key":"2022061622124430600_B30","doi-asserted-by":"crossref","unstructured":"Mather EL, Perry RP. Methylation status and DNase I sensitivity of immunoglobulin genes: changes associated with rearrangement. Proc Natl Acad Sci U S A\u20081983; 80: 4689\u201393.","DOI":"10.1073\/pnas.80.15.4689"},{"key":"2022061622124430600_B31","doi-asserted-by":"crossref","unstructured":"Storb U, Arp B. Methylation patterns of immunoglobulin genes in lymphoid cells: correlation of expression and differentiation with undermethylation. Proc Natl Acad Sci U S A\u20081983; 80: 6642\u20136.","DOI":"10.1073\/pnas.80.21.6642"},{"key":"2022061622124430600_B32","doi-asserted-by":"crossref","unstructured":"Nyce JW. Drug-induced DNA hypermethylation: a potential mediator of acquired drug resistance during cancer chemotherapy. Mutat Res\u20081997; 386: 153\u201361.","DOI":"10.1016\/S1383-5742(96)00051-8"},{"key":"2022061622124430600_B33","doi-asserted-by":"crossref","unstructured":"Wachsman JT. DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. Mutat Res\u20081997; 375: 1\u20138.","DOI":"10.1016\/S0027-5107(97)00003-1"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/17\/8455\/2552274\/8455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/17\/8455\/2552274\/8455.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T20:18:56Z","timestamp":1655410736000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/17\/8455\/526008\/Analysis-of-Genetic-Alterations-and-Clonal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":33,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2006,9,1]]},"published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-4015","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494141","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494141.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22364330.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22364330","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,1]]}}}